Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00591279 · ClinicalTrials.gov registry record

Cancer Control Following Polypectomy

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
110
Enrollment target

NCT00591279: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00591279 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00591279 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
110 participants
Enrollment target

Study Summary

This study evaluates strategies for the surveillance of post-polypectomy patients for the control of bladder cancer

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 1981-02
Est. Completion 2017-01

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT00591279

The ClinicalTrials.gov registry entry for NCT00591279 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00591279 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00591279 about?

NCT00591279 is a clinical study titled "Cancer Control Following Polypectomy". This study evaluates strategies for the surveillance of post-polypectomy patients for the control of bladder cancer

What is the current status of trial NCT00591279?

This trial is currently completed. The enrollment target is 110 participants. The study started on 1981-02. Estimated completion is 2017-01.

Who is sponsoring clinical trial NCT00591279?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.